Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net – Burnie Online News
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEAVanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.The research was led by Lisa Monteggia,……
Continue Reading
-
Noosa News21 hours agoBrisbane’s new bus timetable sees journey times decrease by two minutes in first three months
-
Noosa News23 hours agoGovernment auditors suspected lab was conducting shonky tests on infrastructure projects
-
Business20 hours agoWhat it means for shareholders
-
Business13 hours agoMacquarie tips more than 20% upside for this ASX mining stock